TipRanks
Benitec Biopharma Ltd (DE:BJ9)
FRANKFURT:BJ9
Germany Market
BJ9
Benitec Biopharma
RESEARCH TOOLSreports

Benitec Biopharma (BJ9) Stock News & Sentiment

0 Followers
BB-301 Momentum, Favorable FDA Feedback Support Buy Rating with Unchanged $32 Price Target
Premium
Ratings
BB-301 Momentum, Favorable FDA Feedback Support Buy Rating with Unchanged $32 Price Target
2d ago
BNTC
FDA Clarity on BB-301 Phase 3 Supports Buy Rating on BNTC; $17 Price Target Reiterated
Premium
Ratings
FDA Clarity on BB-301 Phase 3 Supports Buy Rating on BNTC; $17 Price Target Reiterated
2d ago
BNTC
Benitec advances BB-301 gene therapy after FDA feedback
Premium
Company Announcements
Benitec advances BB-301 gene therapy after FDA feedback
3d ago
8K
BNTC
BNTC: BB-301 Clinical Progress and Strong Cash Position Drive Ritu Baral’s Buy Rating
Premium
Ratings
BNTC: BB-301 Clinical Progress and Strong Cash Position Drive Ritu Baral’s Buy Rating
22d ago
BNTC
Benitec Biopharma Announces Board Changes and New Director
Premium
Company Announcements
Benitec Biopharma Announces Board Changes and New Director
4M ago
8K
BNTC
Benitec Biopharma: Buy Rating Reiterated on Promising BB-301 Data and Solid Cash Runway; $32 Price Target Maintained
Premium
Ratings
Benitec Biopharma: Buy Rating Reiterated on Promising BB-301 Data and Solid Cash Runway; $32 Price Target Maintained
4M ago
BNTC
Benitec Biopharma Reaffirmed at Buy on Strong Cash Runway and Clear BB-301 Pivotal Path in OPMD Dysphagia
Premium
Ratings
Benitec Biopharma Reaffirmed at Buy on Strong Cash Runway and Clear BB-301 Pivotal Path in OPMD Dysphagia
5M ago
BNTC
More DE:BJ9 News >

BJ9 News on the Web

BNTC: BB-301 Clinical Progress and Strong Cash Position Drive Ritu Baral’s Buy Rating
TipRanks News
Bullish
Benitec Biopharma price target raised to $17 from $16 at Wedbush
TipRanks News
Bullish
Benitec Biopharma downgraded to Neutral from Buy at Guggenheim
TipRanks News
Neutral
Benitec Biopharma Announces Board Changes and New Director
TipRanks News
Bearish
Benitec Biopharma: Buy Rating Reiterated on Promising BB-301 Data and Solid Cash Runway; $32 Price Target Maintained
TipRanks News
Bullish
Leerink Partners Keeps Their Buy Rating on Benitec Biopharma (BNTC)
TipRanks News
Bullish
Benitec Biopharma Reaffirmed at Buy on Strong Cash Runway and Clear BB-301 Pivotal Path in OPMD Dysphagia
TipRanks News
Bullish
Is Benitec Biopharma (BNTC) Fairly Valued After Q3 FY2026 Earnings? EPS -0.24 vs est. -0. ...
GuruFocus News
Neutral

News Score - Last 7 Days

Very Positive
DE:BJ9
Sector Average
Media Buzz
This Week4 articles
Weekly Average2 articles
News Sentiment
This Week100%
Sector Average91%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DE:BJ9’s Media Buzz Sentiment?
4 articles about DE:BJ9 were published this week. In an average week, 2 articles are published.
    What is DE:BJ9’s weekly average amount of articles?
    In an average week, 2 articles about DE:BJ9 are published.
      What is DE:BJ9’s News Sentiment?
      100% of articles about DE:BJ9 were positive this week, compared to its sector average of 91%.
        Healthcare Stocks that are Trending in the News
        XENEXenon
        ABTAbbott Laboratories
        BBIOBridgeBio Pharma
        BDXBecton Dickinson
        NVSNovartis
        Showing the stocks with the most bullish news sentiment over the past week